| abstract |
Colin alphosserato is a drug useful for the treatment of cognitive impairment associated with cerebrovascular disease and neurodegenerative disease, has been proven to be safe, has no effect on the kidneys and liver, and has been reported to have serious side effects. Not a drug. When administered to patients suffering from neuropathic pain, the pain intensity and the frequency of occurrence of neuropathic pain can be reduced. Therefore, it can be used as an active ingredient of a pharmaceutical composition for treating or preventing neuropathic pain and a health functional food composition for improving neuropathic pain. It can also be used as a method for treating neuropathic pain by administering choline alphoscerato. In addition, choline alphosserato can be used for the preparation of therapeutic agents for neuropathic pain. |